Abstract
The paper offers a survey on literature data on the very wide subject concerning the interaction of a particular class of polyphenols, flavonoids, with plasma proteins. Recent developments in applying fluorescence (steady-state, time-resolved, synchronous techniques), circular dichroism and vibrational (FTIR and Raman) spectroscopies for obtaining relevant parameters (binding constant, K, number of binding sites, thermodynamic effects) are presented. Attention is paid to the modifications occurring upon the interaction process in the secondary and tertiary protein structure, as well as in the ligand conformation. In this case, we underline the significant role played by analyzing the induced dichroic signals of the ligand forced to adopt a restricted conformation in the protein pocket. In order to better understand the molecular aspects of the binding process, the differences in experimental data are discussed in terms of the structural elements of flavonoids, namely the number and position of the OH groups, the presence of methoxy and glycosidic residues and the character of the C2–C3 bond in the A ring. Some correlations of logK with parameters such as the hydrophobicity, hydrogen bond donor and acceptor character, and polar surface are also discussed. In the last section we present the representative theoretical results obtained insofar on both isolated ligands (by DFT and TDDFT methods) and supramolecular ligand–protein systems (by molecular mechanics and dynamics).
Keywords: Binding affinity, circular dichroism, flavonoids, fluorescence, molecular modeling, polyphenol, serum albumin.
Current Drug Metabolism
Title:New Insights on Flavonoid-Serum Albumin Interactions from Concerted Spectroscopic Methods and Molecular Modeling
Volume: 14 Issue: 4
Author(s): Sorana Ionescu, Iulia Matei, Cristina Tablet and Mihaela Hillebrand
Affiliation:
Keywords: Binding affinity, circular dichroism, flavonoids, fluorescence, molecular modeling, polyphenol, serum albumin.
Abstract: The paper offers a survey on literature data on the very wide subject concerning the interaction of a particular class of polyphenols, flavonoids, with plasma proteins. Recent developments in applying fluorescence (steady-state, time-resolved, synchronous techniques), circular dichroism and vibrational (FTIR and Raman) spectroscopies for obtaining relevant parameters (binding constant, K, number of binding sites, thermodynamic effects) are presented. Attention is paid to the modifications occurring upon the interaction process in the secondary and tertiary protein structure, as well as in the ligand conformation. In this case, we underline the significant role played by analyzing the induced dichroic signals of the ligand forced to adopt a restricted conformation in the protein pocket. In order to better understand the molecular aspects of the binding process, the differences in experimental data are discussed in terms of the structural elements of flavonoids, namely the number and position of the OH groups, the presence of methoxy and glycosidic residues and the character of the C2–C3 bond in the A ring. Some correlations of logK with parameters such as the hydrophobicity, hydrogen bond donor and acceptor character, and polar surface are also discussed. In the last section we present the representative theoretical results obtained insofar on both isolated ligands (by DFT and TDDFT methods) and supramolecular ligand–protein systems (by molecular mechanics and dynamics).
Export Options
About this article
Cite this article as:
Ionescu Sorana, Matei Iulia, Tablet Cristina and Hillebrand Mihaela, New Insights on Flavonoid-Serum Albumin Interactions from Concerted Spectroscopic Methods and Molecular Modeling, Current Drug Metabolism 2013; 14 (4) . https://dx.doi.org/10.2174/1389200211314040010
DOI https://dx.doi.org/10.2174/1389200211314040010 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
Call for Papers in Thematic Issues
Impact of brain tissue binding and plasma protein binding of drugs in DMPK
The impression of brain tissue binding (BTB) or plasma protein binding (PPB) in Drug Metabolism and Pharmacokinetics is critical to understanding the distribution, efficacy, and potential toxicity of drugs that target the central nervous system (CNS). BTB and high PPB influence the distribution of drugs in the body and their ...read more
Interaction between drugs and endocrine diseases
The introduction of highly active antiretroviral therapy accelerated studies and our understanding on the interaction between pharmacological therapies and endocrine diseases. Drugs can precipitate endocrine via different mechanisms, including direct alteration of hormone production and secretion, dysregulation of hormonal axis, effects on hormonal transport, receptor-binding, and cellular signalling. Common drug-induced ...read more
Metabolism-Mediated Xenobiotic Toxicity
Considering the potent modulation of biotransformation enzyme expression and activities by various therapeutic drugs and environmental chemicals, and the commonly combined exposure of humans to both drugs and the ever increasing environmental pollutants simultaneously, knowledge about the combined toxic effects by modulating biotransformation enzymes, such as P450s, UDP- glucuronosyltransferases, and ...read more
Safety evaluation of vaccine combination
Vaccine combination safety evaluation is a critical field within immunology and public health that focuses on assessing the safety and efficacy of combining different vaccines to maximize protection against various diseases while minimizing potential adverse effects. This process is significant because it ensures that vaccines can be administered together without ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Treatments of Primary Sclerosing Cholangitis
Current Medicinal Chemistry 177Lu-DOTA-Bevacizumab: Radioimmunotherapy Agent for Melanoma
Current Radiopharmaceuticals Can Colorectal Cancer be Prevented or Treated by Oral Hormone Replacement Therapy?
Current Molecular Pharmacology Theranostic Aspects: Treatment of Cancer by Nanotechnology
Mini-Reviews in Medicinal Chemistry The Metabolite Trimethylamine-N-Oxide is an Emergent Biomarker of Human Health
Current Medicinal Chemistry 18F-FDG PET/CT Demonstrates Efficacy and Limitations of Hepatic Arterial Infusion Chemotherapy for Treating Colorectal Liver Metastases
Current Radiopharmaceuticals Molecular Docking Studies of Naringenin and its Protective Efficacy against Methotrexate Induced Oxidative Tissue Injury
Anti-Cancer Agents in Medicinal Chemistry The Redox Regulation of Thiol Dependent Signaling Pathways in Cancer
Current Pharmaceutical Design Dendritic Cells for Active Anti-Cancer Immunotherapy: Targeting Activation Pathways Through Genetic Modification
Endocrine, Metabolic & Immune Disorders - Drug Targets Synthetic Hammerhead Ribozymes as Therapeutic Tools to Control Disease Genes
Current Gene Therapy Drug Conjugated Nanomedicine as Prodrug Carrier
Nanoscience & Nanotechnology-Asia Structure-Based Drug Design to Overcome Drug Resistance: Challenges and Opportunities
Current Pharmaceutical Design Isothymusin, a Potential Inhibitor of Cancer Cell Proliferation: An In Silico and In Vitro Investigation
Current Topics in Medicinal Chemistry On Therapeutic Drug Monitoring of Thiopurines in Inflammatory Bowel Disease; Pharmacology, Pharmacogenomics, Drug Intolerance and Clinical Relevance
Current Drug Metabolism Peptides as Carrier for Tumor Diagnosis and Treatment
Current Medicinal Chemistry - Anti-Cancer Agents Signal Transduction Therapy for Cancer - Whither Now?
Current Signal Transduction Therapy Adiponectin as a Potential Therapeutic Target for Prostate Cancer
Current Pharmaceutical Design Epigenetics in Vascular Disease – Therapeutic Potential of New Agents
Current Vascular Pharmacology Gedunin, A Neem Limonoid in Combination with Epalrestat Inhibits Cancer Hallmarks by Attenuating Aldose Reductase-Driven Oncogenic Signaling in SCC131 Oral Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry A Uniquely Modified DKL-based Peptide Probe for Positron Emission Tomography Imaging
Current Pharmaceutical Design